美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

美國抗疫概念

1,768.64

-9.6105-0.54%

漲家數：12

跌家數：7

平家數：- -

市盈率：- -

高：1,781.39

開：1,777.80

低：1,756.89

收：1,778.25

成交量：8,072.63萬

成交額：48.99億

市值：1.44萬億

流通市值：1.42萬億

資料載入中...

總覽新聞資訊

美國疾控中心推遲發布顯示 COVID 疫苗益處的報告 --《華郵》報導

代理疾控中心主任質疑研究方法有效性，但該設計長期用於疫苗效果評估

優寧維：與禮來（中國）研發有限公司、阿斯利康投資（中國）有限公司有過業務合作

雷克蘭醫療工業再獲哥倫比亞國家消防部門緊急追加訂單提供全方位消防裝備

BUZZ-Truist 上調吉利德 PT，因預期第一季度業績與預期一致

BUZZ-iBio股價上漲，因肥胖症藥物獲准在澳進行首次人體試驗

BUZZ-巴克萊因收購 Exact Sciences 上調雅培目標價

諾瓦瓦克斯醫藥盤前股價飆升6.1%；維權投資者Shah Capital宣佈將投票反對公司高管薪酬及董事提名

Shah Capital 打算對 Novavax 董事會提名人選和高管薪酬投反對票

Shah Capital敦促諾瓦瓦克斯醫藥贖回2.25億美元可轉債及/或啓動1000萬至2000萬股回購計劃

全球生物醫藥巨頭阿斯利康落子廣州；深圳即將啓用廣東首個機器人停車場丨大灣區財經早參

每日经济新闻

Equillium Inc. 股東售股計劃：包含可行使預融資權證發行的1770萬股

吉利德科學再度出手收購癌症藥物合作伙伴——市場快訊

今日優惠-合併與收購

吉利德科學將收購Tubulis，引入潛在同類最佳抗體偶聯藥物及新一代平台，進一步強化腫瘤產品管線

吉利德將以高達 50 億美元的價格收購 Tubulis GmbH

吉利德科學將以31.5億美元現金預付款收購Tubulis，潛在里程碑金額高達18.5億美元

吉利德科學將以31.5億美元現金收購Tubulis全部流通股權，交易基於無現金無債務基礎

吉利德科學斥資31.5億美元現金收購德國生物技術公司Tubulis，交易總價值最高可達50億美元。

強生歐洲推出Varipulse Pro，推進脈衝電場消融產品組合

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4568/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美國抗疫概念","latestPrice":1768.637,"timestamp":1776283199999,"preClose":1778.2474,"halted":0,"volume":80726267,"delay":0,"changeRate":-0.005404,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-9.610474,"latestTime":"04-15 16:00:00 EDT","open":1777.8021,"high":1781.3911,"low":1756.8928,"amount":4898574199.810622,"amplitude":0.013777,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1776346200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.461208,"peRate":29.136252,"turnoverRate":0.005825,"increases":12,"decrements":7,"flats":0,"marketCap":1443733597404,"floatMarketCap":1422122269026},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1781.3911,"amplitude":0.013777,"preClose":1778.2474,"low":1756.8928,"pbRate":"4.461208","latestPrice":1768.637,"volume":80726267,"delay":0,"open":1777.8021,"prevYearClose":1637.1339,"prevWeekClose":1764.6329,"prevMonthClose":1781.5065,"prevQuarterClose":1781.5065,"fiveDayClose":1789.0016,"twentyDayClose":1775.5172,"sixtyDayClose":1690.7542,"secType":"PLATE","market":"US","turnoverRate":0.005825,"peRate":29.136252,"marketCap":1443733597404,"floatMarketCap":1422122269026,"timestamp":1776283199999,"nameCN":"美國抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":12,"down":7,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2626900375","title":"美國疾控中心推遲發布顯示 COVID 疫苗益處的報告 --《華郵》報導","url":"https://stock-news.laohu8.com/highlight/detail?id=2626900375","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626900375?lang=zh_tw&edition=fundamental","pubTime":"2026-04-09 17:10","pubTimestamp":1775725840,"startTime":"0","endTime":"0","summary":"美国疾控中心推迟发布显示 COVID 疫苗益处的报告 --《华邮》报导路透4月9日 - 据《华盛顿邮报》周四援引熟悉这一决定的科学家的话报导，美国疾病控制与预防中心代理主任已推迟公布疾控中心的一份报告，该报告显示，新冠疫苗可将去年冬天健康成年人到急诊室就诊和住院的可能性降低一半左右。路透无法立即核实该报导。卫生与公众服务部没有立即回应置评请求。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nL4T40S0LW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","LU0321505868.SGD","LU0456855351.SGD","BK4551","BK4592","LU0868494617.USD","LU1066051498.USD","LU0122379950.USD","IE00B19Z3581.USD","BK4585","IE0002270589.USD","LU0225284248.USD","LU1066053197.SGD","LU0289739699.SGD","LU1023059063.AUD","SG9999001176.USD","SG9999001176.SGD","BK4007","BK4533","LU0058720904.USD","LU0321505439.SGD","LU1894683264.USD","LU1057294990.SGD","LU0225771236.USD","SG9999002232.USD","BK4139","BK4534","LU1894683348.USD","SG9999002224.SGD","BK4501","IE000M9KFDE8.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","BK4548","BK4588","IE00BBT3K403.USD","BK4532","BK4599","BK4581","IE00B19Z3B42.SGD","SGXZ57979304.SGD","MRNY","SG9999013999.USD","SG9999003800.SGD","BK4568","LU0306807586.USD","LU0170899867.USD","BK4547","LU0985481810.HKD","BK4550","LU0306806265.USD","LU1883839398.USD","SG9999011175.SGD","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157802825","title":"代理疾控中心主任質疑研究方法有效性，但該設計長期用於疫苗效果評估","url":"https://stock-news.laohu8.com/highlight/detail?id=1157802825","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157802825?lang=zh_tw&edition=fundamental","pubTime":"2026-04-09 17:05","pubTimestamp":1775725546,"startTime":"0","endTime":"0","summary":"代理美国疾病控制与预防中心主任近日对某项研究采用的方法论提出质疑，认为其可能存在设计缺陷。值得注意的是，被质疑的研究设计框架在疫苗有效性验证领域已有长期应用历史，曾被多项权威研究采纳作为评估标准。这种看似矛盾的现象凸显出科研领域方法论选择与结果解读之间的复杂平衡。专家指出，同一研究设计在不同应用场景下可能产生差异化结论，需结合具体研究目标进行综合判断。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999013999.USD","BK4585","LU0170899867.USD","BK4550","LU1057294990.SGD","SG9999002224.SGD","BK4568","SGXZ57979304.SGD","LU0289739699.SGD","IE0002270589.USD","BK4581","LU0058720904.USD","IE00BLSP4452.SGD","SG9999002232.USD","IE00BBT3K403.USD","LU0234572021.USD","IE00B19Z3581.USD","SG9999003800.SGD","LU0306807586.USD","IE00BLSP4239.USD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU1894683264.USD","BK4588","LU1894683348.USD","SG9999011175.SGD","LU0868494617.USD","LU0456855351.SGD","BK4599","SG9999001176.USD","LU1023059063.AUD","LU0122379950.USD","BK4007","LU0225771236.USD","SG9999001176.SGD","BK4534","LU1066053197.SGD","LU0321505868.SGD","LU0321505439.SGD","BK4533","LU1883839398.USD","LU0985481810.HKD","CDC","LU0306806265.USD","LU1066051498.USD","BK4592","LU0225284248.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626902391","title":"優寧維：與禮來（中國）研發有限公司、阿斯利康投資（中國）有限公司有過業務合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2626902391","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626902391?lang=zh_tw&edition=fundamental","pubTime":"2026-04-09 16:12","pubTimestamp":1775722321,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维(301166)04月09日在投资者关系平台上答复投资者关心的问题。投资者提问：冷总，您好公司有没有和礼来阿斯利康合作？优宁维回复：投资者您好，公司作为生命科学一站式服务商平台，可提供生命科学所涉及的生物试剂及相关仪器、耗材和综合技术服务。公司与礼来(中国)研发有限公司、阿斯利康投资(中国)有限公司有过业务合作，双方交易规模较小，对公司业绩不构成重大影响。谢谢。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260409/32133822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU2361044949.HKD","IE00BFSS8Q28.SGD","IE00B1XK9C88.USD","LU2237443382.USD","LU2265009873.SGD","LU2028103732.USD","ELIS","IE0002141913.USD","LU1291159041.SGD","LU0689472784.USD","LU1720051108.HKD","LU2168564149.EUR","LU2089284900.SGD","LU2089984988.USD","LU0198837287.USD","IE00B4R5TH58.HKD","LU2746668974.SGD","LU2552382058.USD","IE00B775H168.HKD","LU0353189763.USD","LU0238689110.USD","LU1629891620.HKD","LU1868837300.USD","LU2361044865.SGD","LU0432979614.USD","LU1069344957.HKD","LU0708995401.HKD","LU2552382215.SGD","IE00B2B36J28.USD","LU1280957306.USD","IE00BFSS7M15.SGD","LU2264538146.SGD","SG9999001176.USD","SG9999015986.USD","SGXZ99366536.SGD","IE00BJT1NW94.SGD","LU0385154629.USD","LU2462157665.USD","LU2361045086.USD","SG9999018857.SGD","LU1323610961.USD","LU0006306889.USD","LU2750360641.GBP","BK4581","LU2491049909.HKD","LU0079474960.USD","LU1057294990.SGD","IE00BK4W5L77.USD","LU0466842654.USD","SG9999014880.SGD","SG9999014898.SGD","SGXZ31699556.SGD","LU0820561909.HKD","SG9999017495.SGD","LU2271345857.HKD","LU1829250122.USD","IE0004445239.USD","LU0114720955.EUR","LU0456855351.SGD","LU0225283273.USD","BK4599","LU1035775433.USD","LU2360106947.USD","LU2023250504.SGD","LLII","LU0058720904.USD","LU0106261372.USD","LU0266013472.USD","LU2211815571.USD","BK4568","LU1145028129.USD","LU2168564222.USD","SG9999014906.USD","IE00BKDWB100.SGD","LU2168564495.EUR","IE00BJJMRY28.SGD","LU2746668461.USD","IE00B1BXHZ80.USD","LU0210536198.USD","IE00BK4W5M84.HKD","LU1093756325.SGD","LU0640476718.USD","LU0320765059.SGD","LU2112291526.USD","LU1814569148.SGD","SG9999018865.SGD","SGXZ51526630.SGD","LU2023251221.USD","LU0094547139.USD","LU2237443465.HKD","SGXZ57979304.SGD","LU0889565916.HKD","SGXZ81514606.USD","LU2471134952.CNY","LU2168563687.JPY","LU2063271972.USD","LU2237438978.USD","LU0823416689.USD","LU0353189680.USD","LU1127390331.HKD","IE00BJJMRX11.SGD","LU0964807845.USD","LLYX","BK4534","LLYZ","LU0787776722.HKD","LU1623119135.USD","LU1061106388.HKD","LU0061475181.USD","LU0234572021.USD","SG9999014914.USD","LU0316494557.USD","LU2552382132.HKD","LU2468319806.SGD","IE0009355771.USD","IE00BN29S564.USD","LU1989771016.USD","SG9999001176.SGD","IE00BJJMRZ35.SGD","LU2168564065.EUR","LU2236285917.USD","LU1064131342.USD","LU2237443895.HKD","SG9999015952.SGD","BK4516","LU0256863902.USD","LU2417539215.USD","IE00B3T34201.USD","LU1868836914.USD","LU1974910355.USD","LU1868837136.USD","LU2111349929.HKD","LU1868836591.USD","LU2108987350.USD","LU2324357040.USD","LU2357305700.SGD","LU2237443978.SGD","LU1551013342.USD","LU0471298694.HKD","IE00BKPKM429.USD","LU1551013425.SGD","LU2471134796.USD","LU1023059063.AUD","LU1366192091.USD","LU0354030511.USD","BK4007","LU1720051017.SGD","LU1804176565.USD","LU0096364046.USD","LU2456880835.USD","LU2756315664.SGD","LU0786609619.USD","SG9999013999.USD","LU0672654240.SGD","LU2106854487.HKD","LU0882574139.USD","LU0289739699.SGD","LU1983299246.USD","LU2089283258.USD","LU2896262040.SGD","BK0250","LU2471134879.HKD","IE00BWXC8680.SGD","LU0109394709.USD","BK4588","ELIL","LU0943347566.SGD","LU0323591593.USD","LU0158827948.USD","LU1232071149.USD","IE00BFTCPJ56.SGD","GB00BDT5M118.USD","IE00B4JS1V06.HKD","BK4585","LU0882574055.USD","LU1093756168.USD","LU2756315318.SGD","SG9999015945.SGD","301166","LU1548497426.USD","LU1868836757.USD","LU1267930730.SGD","LU0256863811.USD","LU1712237335.SGD","LU0823434740.USD","IE00BJLML261.HKD","LU0471298777.SGD","LU2461242641.AUD","LU0158827781.USD","IE0004445015.USD","SG9999015978.USD","IE0001KFT4U8.USD","LU0203202063.USD","LU2023250330.USD","LU0823434583.USD","LU2087625088.SGD","LU1917777945.USD","IE0005OL40V9.USD","BK4533","IE00B7KXQ091.USD","LU1988902786.USD","LU0820561818.USD","LU2213496289.HKD","LU0820562030.AUD","LU2237443622.USD","LU2491050071.SGD","LU2491050154.USD","LU0320765992.SGD","LU2471134523.USD","LU2602419157.SGD","LU0097036916.USD","LU2750360997.AUD","LU0417517546.SGD","LU0683600562.USD","LU0109391861.USD","LU0354030438.USD","LU2237443549.SGD","LU0122379950.USD","LU0203201768.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147877060","title":"雷克蘭醫療工業再獲哥倫比亞國家消防部門緊急追加訂單 提供全方位消防裝備","url":"https://stock-news.laohu8.com/highlight/detail?id=1147877060","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147877060?lang=zh_tw&edition=fundamental","pubTime":"2026-04-08 20:40","pubTimestamp":1775652040,"startTime":"0","endTime":"0","summary":"雷克兰医疗工业（Lakeland Fire + Safety）近日成功获得哥伦比亚国家消防部门发出的紧急追加采购订单，将为该部门提供从头到脚的全套消防防护装备。此次订单属于紧急后续采购，凸显了客户对雷克兰产品品质与应急供应能力的持续认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","IE00B66KJ199.SGD","IE00B19Z4B17.USD","IE0031619046.USD","IE00B7SZL793.SGD","LAKE","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625945292","title":"BUZZ-Truist 上調吉利德 PT，因預期第一季度業績與預期一致","url":"https://stock-news.laohu8.com/highlight/detail?id=2625945292","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625945292?lang=zh_tw&edition=fundamental","pubTime":"2026-04-08 19:48","pubTimestamp":1775648897,"startTime":"0","endTime":"0","summary":"4月8日 - ** Truist Securities将制药商吉利德科学GILD.O的PT值从152美元上调至155美元，维持\"买入 \"评级。** 新的PT较该股上次收盘价上涨11.7%** Truist预计第一季度业绩与华尔街预期基本一致** 预计第一季度营收为 69.4 亿美元，分析师一致预期为 69.1 亿美元；非美国通用会计准则每股收益为 1.84 美元，一致预期为 1.90 美元。** 预计第一季度艾滋病药物 Biktarvy 的销售额为 33 亿美元，而华尔街预期为 33.4 亿美元；预计 PrEP 药物 Yeztugo 的销售额为 1.67 亿美元，而华尔街预期为 1.51 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nL4S40R11F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1778281490.HKD","BK4585","LU1839511570.USD","LU2324357040.USD","LU0289739699.SGD","SG9999015978.USD","BK4550","LU2087621335.USD","LU0122379950.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","LU0965509010.AUD","LU1037948897.HKD","LU1057294990.SGD","LU1066051498.USD","IE00B19Z3B42.SGD","BK4588","LU2112291526.USD","IE00B7SZLL34.SGD","LU0234570918.USD","SG9999015986.USD","BK4578","LU0965509283.SGD","LU2468319806.SGD","SG9999015952.SGD","IE00BKVL7J92.USD","BK4583","LU0965508806.USD","LU1585245621.USD","LU1934455194.USD","GILD","LU1934455277.USD","LU1674673691.USD","IE00B19Z3581.USD","LU1037948541.HKD","LU0114720955.EUR","LU0823416689.USD","LU1023059063.AUD","BK4566","LU0320765992.SGD","SG9999015945.SGD","IE00B3T34201.USD","IE00BSNM7G36.USD","BK4568","LU0861579265.USD","LU1061106388.HKD","LU1571399168.USD","LU1674673428.USD","LU1934455863.HKD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625943915","title":"BUZZ-iBio股價上漲，因肥胖症藥物獲准在澳進行首次人體試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2625943915","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625943915?lang=zh_tw&edition=fundamental","pubTime":"2026-04-08 19:11","pubTimestamp":1775646709,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nL4T40R0Z5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBIO","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625294846","title":"BUZZ-巴克萊因收購 Exact Sciences 上調雅培目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=2625294846","media":"路透中文","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625294846?lang=zh_tw&edition=fundamental","pubTime":"2026-04-08 18:54","pubTimestamp":1775645644,"startTime":"0","endTime":"0","summary":"4月8日 - ** 巴克莱银行将医疗设备制造商雅培实验室ABT.N的**目标价**从142美元上调至144美元 ** 重申 \"增持 \"评级** 巴克莱称其更新了模型，以反映雅培对Exact Sciences  的收购，上调了收入预期，同时考虑到了近期的盈利稀释。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nL4S40R0XY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU2237957811.SGD","BK4568","IE00BJJMRZ35.SGD","SG9999004303.SGD","LU0114720955.EUR","IE00BJT1NW94.SGD","LU2089984988.USD","BK4082","BK4585","LU0868494617.USD","LU2211815571.USD","LU1023059063.AUD","LU1989763690.USD","IE0002141913.USD","SG9999002232.USD","IE00B2B36J28.USD","SGXZ23171101.USD","LU2237957902.USD","LU0882574055.USD","BK4533","BK4581","LU0058720904.USD","BK4566","LU1061106388.HKD","LU0266013472.USD","LU0289739699.SGD","LU1721429741.USD","LU2324357040.USD","SG9999002224.SGD","LU1989763427.SGD","LU1057294990.SGD","LU0122379950.USD","LU0170899867.USD","LU0234572021.USD","BK4504","IE00B4R5TH58.HKD","LU2112291526.USD","IE00BFTCPJ56.SGD","LU1691799644.USD","LU2468319806.SGD","LU2133065610.SGD","ABT","LU1914381329.SGD","BK4592","SGXZ41872573.SGD","LU1721429402.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138462511","title":"諾瓦瓦克斯醫藥盤前股價飆升6.1%；維權投資者Shah Capital宣佈將投票反對公司高管薪酬及董事提名","url":"https://stock-news.laohu8.com/highlight/detail?id=1138462511","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138462511?lang=zh_tw&edition=fundamental","pubTime":"2026-04-08 18:07","pubTimestamp":1775642839,"startTime":"0","endTime":"0","summary":"诺瓦瓦克斯医药（NVAX）股价在盘前交易时段大幅上涨6.1%，引发市场关注。与此同时，知名维权投资机构Shah Capital公开表示，将在公司即将举行的股东大会上对高管薪酬方案及董事会候选人名单投下反对票。\n这一股价异动与股东积极行动同时出现，凸显了市场对诺瓦瓦克斯医药公司治理状况的高度关注。Shah Capital作为长期关注公司治理的活跃投资者，此次采取反对立场可能影响其他机构投资者的投票决策。\n目前，诺瓦瓦克斯医药尚未就此事发表官方评论。市场分析师指出，此类股东行动通常反映了投资者对公司战略方向或管理层表现的不满，可能促使公司重新评估其治理结构。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","BK4568","BK4588","BK4547","NVAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625191794","title":"Shah Capital 打算對 Novavax 董事會提名人選和高管薪酬投反對票","url":"https://stock-news.laohu8.com/highlight/detail?id=2625191794","media":"路透中文","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625191794?lang=zh_tw&edition=fundamental","pubTime":"2026-04-08 18:02","pubTimestamp":1775642554,"startTime":"0","endTime":"0","summary":"Shah Capital 打算对 Novavax 董事会提名人选和高管薪酬投反对票Sneha S K/Sriparna Roy路透4月8日 - 激进投资者 Shah Capital计划在 Novavax NVAX.O即将召开的年会上投票反对董事会提名人的改选和高管薪酬方案，再次向这家疫苗生产商施加压力，要求其进行变革。Shah Capital 持有 Novavax 9% 的股份，是该公司的第二大股东，它一直在推动这家生物技术公司的董事会进行战略调整，包括潜在的出售。本周三，沙阿表示，他不会发起代理权争夺战，\"因为这将是少数人对抗根深蒂固的八人董事会\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nL4T40R0VP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Shah Capital 打算对 Novavax 董事会提名人选和高管薪酬投反对票","news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","NVAX","BK4139","BK4588","BK4585","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185735364","title":"Shah Capital敦促諾瓦瓦克斯醫藥贖回2.25億美元可轉債及/或啓動1000萬至2000萬股回購計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=1185735364","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185735364?lang=zh_tw&edition=fundamental","pubTime":"2026-04-08 18:00","pubTimestamp":1775642419,"startTime":"0","endTime":"0","summary":"知名投资机构Shah Capital近日公开呼吁生物技术公司诺瓦瓦克斯医药采取积极资本管理措施，建议其尽快赎回市场上流通的2.25亿美元可转换债券，同时考虑启动规模达1000万至2000万股的股票回购计划。通过削减债务规模和回购股份，诺瓦瓦克斯医药有望优化资本结构，进一步提升每股收益指标。值得注意的是，诺瓦瓦克斯医药作为疫苗研发领域的重要参与者，其资本运作动向备受关注。Shah Capital的建议若被采纳，可能引发连锁市场反应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4547","BK4568","BK4139","NVAX","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625027964","title":"全球生物醫藥巨頭阿斯利康落子廣州；深圳即將啓用廣東首個機器人停車場丨大灣區財經早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2625027964","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625027964?lang=zh_tw&edition=fundamental","pubTime":"2026-04-08 07:05","pubTimestamp":1775603119,"startTime":"0","endTime":"0","summary":"｜2026年4月8日星期三｜NO.1清明假期广东旅游收入超百亿元“广东发布”微信公众号4月7日消息，据初步测算，2026年清明假期三天（4月4日至6日），广东接待游客1985.1万人次，实现旅游收入104.3亿元。点评：百亿文旅收入印证广东内需韧性、消费活力、湾区磁吸效应，为一季度经济收官、二季度内需扩容打下坚实基础。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604083696940526.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604083696940526.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","LU0289739699.SGD","BK4007","LU0058720904.USD","LU2237443382.USD","LU2237443622.USD","LU2236285917.USD","BK4588","LU1829250122.USD","LU2417539215.USD","159983","ROBO","161726","LU2237443465.HKD","LU2462157665.USD","AZN","XBI","BK4581","399441","LU0109394709.USD","LU2456880835.USD","LU0889565916.HKD","LU2237443549.SGD","LU2237443895.HKD","LU2237443978.SGD","LU0320765992.SGD","IE00B3T34201.USD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183859739","title":"Equillium Inc. 股東售股計劃：包含可行使預融資權證發行的1770萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=1183859739","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183859739?lang=zh_tw&edition=fundamental","pubTime":"2026-04-08 05:17","pubTimestamp":1775596630,"startTime":"0","endTime":"0","summary":"Equillium Inc. 宣布其股东售股计划中，包含一项重要条款：通过行使预融资权证，可发行高达1770万股的公司普通股。这一安排为股票的潜在增发提供了明确路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","EQ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130614255","title":"吉利德科學再度出手收購癌症藥物合作伙伴——市場快訊","url":"https://stock-news.laohu8.com/highlight/detail?id=1130614255","media":"投资观察","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130614255?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 22:26","pubTimestamp":1775572014,"startTime":"0","endTime":"0","summary":"吉利德科学公司再度出手收购其癌症药物合作伙伴，该公司已达成协议，将以最高50亿美元的价格收购Tubulis公司。今年二月，吉利德宣布将收购ARCELLX, INC.的全部剩余股份，该公司是吉利德在开发针对多发性骨髓瘤这一血癌的潜在CAR-T细胞疗法方面的合作伙伴，该交易对这家生物技术公司的估值在交易完成时约为78亿美元。\nRBC资本市场的分析师指出，此次收购Tubulis是一项战略上合理的补充性收购，既能满足吉利德肿瘤学产品管线增长的需求，又能确保获得差异化的下一代抗体偶联药物平台能力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","LU1023059063.AUD","LU2324357040.USD","LU0320765992.SGD","IE0002270589.USD","BK4550","LU1066053197.SGD","LU0122379950.USD","IE00B19Z3B42.SGD","LU2087621335.USD","IE00BKVL7J92.USD","LU0234570918.USD","LU1674673428.USD","BK4588","BK4578","LU0889565916.HKD","LU1674673691.USD","LU1778281490.HKD","LU2468319806.SGD","BK4585","LU0965509283.SGD","SG9999015978.USD","LU1061106388.HKD","BK4568","LU1037948541.HKD","SG9999015952.SGD","ACLX","BK4566","LU1934455863.HKD","LU1839511570.USD","SG9999015945.SGD","LU0861579265.USD","LU0289739699.SGD","IE00B3T34201.USD","LU0109394709.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","LU1057294990.SGD","LU0058720904.USD","LU0965508806.USD","LU0882574055.USD","SG9999015986.USD","IE00B7SZLL34.SGD","LU0965509101.SGD","BK4583","LU1571399168.USD","LU1430594728.SGD","BK4532","LU0965509010.AUD","LU2089984988.USD","LU1934455194.USD","LU1037948897.HKD","LU1066051498.USD","LU2112291526.USD","IE00B19Z3581.USD","LU0114720955.EUR","LU1934455277.USD","LU0823416689.USD","IE00BSNM7G36.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625609956","title":"今日優惠-合併與收購","url":"https://stock-news.laohu8.com/highlight/detail?id=2625609956","media":"路透中文","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625609956?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 21:56","pubTimestamp":1775570178,"startTime":"0","endTime":"0","summary":"今日优惠-合并与收购新增 Evotec、吉利德、Senior Plc；更新 Pershing Square路透4月7日 - 截至周二13:30 GMT，报告了以下竞购、兼并、收购和处置：** 德国生物技术公司Evotec link) >  周二表示，该公司将在  向吉利德出售德国私营企业Tubulis的交易完成后获得约1亿美元的预付款   。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nL4S40Q11U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","BK4588","GILD","LU1674673428.USD","IE0004445239.USD","LU1037948541.HKD","BK4566","SG9999015952.SGD","LU0289739699.SGD","IE00BLSP4452.SGD","LU1066051498.USD","LU2089984988.USD","IE00B3T34201.USD","LU0320765992.SGD","LU0823416689.USD","LU0882574055.USD","BK4139","LU0114720955.EUR","LU1585245621.USD","LU1934455277.USD","BK4532","IE00B64PRP62.GBP","SNR.UK","LU0889565916.HKD","LU0965509101.SGD","IE00B19Z3B42.SGD","SG9999015945.SGD","LU0965509010.AUD","BX","LU1674673691.USD","LU1061106388.HKD","LU1066053197.SGD","LU0965508806.USD","LU2324357040.USD","BK4578","BK4135","LU1430594728.SGD","LU1934455194.USD","IE00BKVL7J92.USD","LU2087621335.USD","LU0234570918.USD","BK4568","LU2112291526.USD","SG9999015978.USD","IE00B19Z3581.USD","LU1023059063.AUD","LU0861579265.USD","IE00BSNM7G36.USD","LU0965509283.SGD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109962795","title":"吉利德科學將收購Tubulis，引入潛在同類最佳抗體偶聯藥物及新一代平台，進一步強化腫瘤產品管線","url":"https://stock-news.laohu8.com/highlight/detail?id=1109962795","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109962795?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 20:31","pubTimestamp":1775565084,"startTime":"0","endTime":"0","summary":"吉利德科学宣布收购Tubulis公司，此举将为公司带来潜在同类最优的抗体偶联药物以及新一代技术平台，从而显著增强其在肿瘤治疗领域的产品管线布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0823416689.USD","LU1674673428.USD","IE00B7SZLL34.SGD","BK4139","GILD","LU0965509010.AUD","SG9999015945.SGD","LU0889565916.HKD","LU1037948897.HKD","IE00B19Z3B42.SGD","BK4532","LU1430594728.SGD","LU0109394709.USD","LU1571399168.USD","LU2324357040.USD","IE00B3T34201.USD","LU1839511570.USD","LU0234570918.USD","LU2468319806.SGD","LU1057294990.SGD","LU1674673691.USD","LU0861579265.USD","SG9999015952.SGD","LU2089984988.USD","LU2087621335.USD","BK4550","LU0320765992.SGD","SG9999015978.USD","IE0002270589.USD","IE00BZ1G4Q59.USD","LU1585245621.USD","LU0965509283.SGD","BK4588","BK4566","SG9999015986.USD","LU0114720955.EUR","LU0122379950.USD","IE00BSNM7G36.USD","LU1934455863.HKD","LU0965509101.SGD","LU1066051498.USD","IE00B19Z3581.USD","BK4583","LU0882574055.USD","LU1023059063.AUD","LU1778281490.HKD","LU2112291526.USD","LU0058720904.USD","LU1037948541.HKD","LU1934455194.USD","LU1934455277.USD","LU1061106388.HKD","IE00BKVL7J92.USD","LU0289739699.SGD","LU0965508806.USD","BK4568","LU1066053197.SGD","BK4578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625930700","title":"吉利德將以高達 50 億美元的價格收購 Tubulis GmbH","url":"https://stock-news.laohu8.com/highlight/detail?id=2625930700","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625930700?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 20:19","pubTimestamp":1775564397,"startTime":"0","endTime":"0","summary":"吉利德将以高达 50 亿美元的价格收购 Tubulis GmbH路透4月7日 - 吉利德公司GILD.O周二表示，它将以不超过50亿美元的价格收购总部位于德国的私营企业Tubulis GmbH，这将增强这家美国制药商的产品线，使其拥有被称为 \"制导导弹 \"的一类利润丰厚的实验性抗癌药物。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nL4T40Q0UH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","BK4578","BK4139","LU2112291526.USD","IE00BZ1G4Q59.USD","GILD","LU0882574055.USD","LU1066051498.USD","LU1061106388.HKD","LU1934455277.USD","LU2324357040.USD","LU1037948541.HKD","SG9999015945.SGD","LU0234570918.USD","IE00B3T34201.USD","LU0114720955.EUR","BK4550","LU0889565916.HKD","LU0965508806.USD","LU1839511570.USD","LU2087621335.USD","IE00B19Z3B42.SGD","BK4532","LU1934455194.USD","LU0861579265.USD","LU1934455863.HKD","SG9999015952.SGD","SG9999015986.USD","IE00B7SZLL34.SGD","SG9999015978.USD","LU1585245621.USD","LU2089984988.USD","LU1674673428.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU1037948897.HKD","LU1430594728.SGD","LU1778281490.HKD","BK4568","IE0002270589.USD","LU2468319806.SGD","LU0965509283.SGD","LU0965509010.AUD","LU1674673691.USD","BK4583","LU0823416689.USD","LU0109394709.USD","BK4588","BK4585","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111294591","title":"吉利德科學將以31.5億美元現金預付款收購Tubulis，潛在里程碑金額高達18.5億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111294591","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111294591?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 20:19","pubTimestamp":1775564350,"startTime":"0","endTime":"0","summary":"生物制药巨头吉利德科学宣布达成一项重大收购协议，将以31.5亿美元现金作为预付款，收购专注于抗体偶联药物研发的德国生物技术公司Tubulis。根据协议条款，若Tubulis在后续研发中达成特定里程碑，吉利德还将额外支付最高18.5亿美元的资金。此次交易凸显了吉利德科学在肿瘤治疗领域的战略布局。协议设计的里程碑付款机制，既体现了吉利德对Tubulis技术潜力的认可，也显示出其对研发成果的审慎评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0965509283.SGD","BK4588","LU0823416689.USD","LU2087621335.USD","LU0889565916.HKD","LU1934455277.USD","SG9999015986.USD","LU1674673691.USD","SG9999015978.USD","IE00B19Z3581.USD","LU1066053197.SGD","LU0289739699.SGD","IE00BZ1G4Q59.USD","LU0882574055.USD","LU1571399168.USD","SG9999015945.SGD","LU1934455194.USD","LU0965509101.SGD","BK4585","LU0965508806.USD","LU1023059063.AUD","BK4583","LU0861579265.USD","LU0965509010.AUD","LU1585245621.USD","SG9999015952.SGD","LU0234570918.USD","LU0122379950.USD","LU0320765992.SGD","BK4550","LU1061106388.HKD","LU1674673428.USD","LU1778281490.HKD","LU2468319806.SGD","LU1057294990.SGD","IE00B3T34201.USD","LU2324357040.USD","IE0002270589.USD","LU1839511570.USD","IE00BSNM7G36.USD","LU2112291526.USD","LU0114720955.EUR","BK4566","LU1066051498.USD","BK4532","LU2089984988.USD","BK4568","GILD","LU1934455863.HKD","LU1430594728.SGD","LU0058720904.USD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","LU0109394709.USD","LU1037948541.HKD","IE00BKVL7J92.USD","BK4578","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136489047","title":"吉利德科學將以31.5億美元現金收購Tubulis全部流通股權，交易基於無現金無債務基礎","url":"https://stock-news.laohu8.com/highlight/detail?id=1136489047","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136489047?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 20:18","pubTimestamp":1775564314,"startTime":"0","endTime":"0","summary":"吉利德科学宣布，将以31.5亿美元的前期现金对价，收购生物技术公司Tubulis的全部流通股权。此次交易将基于无现金、无债务的基础进行，标志着吉利德在拓展肿瘤治疗管线方面的重大战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU0114720955.EUR","BK4139","LU1037948541.HKD","LU1585245621.USD","LU1430594728.SGD","LU1934455194.USD","IE00B19Z3B42.SGD","LU1778281490.HKD","LU0289739699.SGD","BK4578","LU2112291526.USD","SG9999015945.SGD","LU0234570918.USD","LU1839511570.USD","LU0122379950.USD","LU1674673428.USD","BK4550","IE00BSNM7G36.USD","BK4585","IE00B3T34201.USD","LU0109394709.USD","LU2087621335.USD","BK4568","LU0320765992.SGD","SG9999015978.USD","BK4583","IE00B7SZLL34.SGD","IE00B19Z3581.USD","LU2468319806.SGD","LU1066053197.SGD","LU2324357040.USD","LU0965509283.SGD","GILD","LU0058720904.USD","LU0965509010.AUD","LU0882574055.USD","BK4532","LU1061106388.HKD","LU1037948897.HKD","LU0861579265.USD","LU1934455863.HKD","SG9999015986.USD","SG9999015952.SGD","LU0823416689.USD","LU2089984988.USD","LU0889565916.HKD","LU1066051498.USD","LU1571399168.USD","LU1934455277.USD","IE0002270589.USD","BK4588","BK4566","LU1674673691.USD","LU1057294990.SGD","LU0965508806.USD","LU1023059063.AUD","LU0965509101.SGD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625930681","title":"吉利德科學斥資31.5億美元現金收購德國生物技術公司Tubulis，交易總價值最高可達50億美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2625930681","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625930681?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 20:03","pubTimestamp":1775563412,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4578","LU1037948897.HKD","LU2324357040.USD","BK4566","SG9999015986.USD","BK4550","LU0965509010.AUD","SG9999015945.SGD","LU1057294990.SGD","SG9999015978.USD","BK4568","IE00B3T34201.USD","GILD","LU0289739699.SGD","LU2112291526.USD","LU0058720904.USD","LU0823416689.USD","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","LU0109394709.USD","LU0320765992.SGD","LU0965509283.SGD","LU1061106388.HKD","IE00B19Z3B42.SGD","LU1571399168.USD","LU1839511570.USD","BK4588","FDXMmain","IE00BSNM7G36.USD","LU2089984988.USD","BK4532","IE00B7SZLL34.SGD","LU0861579265.USD","IE00BKVL7J92.USD","FDXSmain","LU1934455277.USD","LU1037948541.HKD","LU1023059063.AUD","LU0122379950.USD","LU1778281490.HKD","LU1934455863.HKD","LU1674673691.USD","LU0889565916.HKD","LU1066053197.SGD","LU0965509101.SGD","FDAXmain","LU1430594728.SGD","LU0965508806.USD","LU0882574055.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184072442","title":"強生歐洲推出Varipulse Pro，推進脈衝電場消融產品組合","url":"https://stock-news.laohu8.com/highlight/detail?id=1184072442","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184072442?lang=zh_tw&edition=fundamental","pubTime":"2026-04-07 20:01","pubTimestamp":1775563303,"startTime":"0","endTime":"0","summary":"强生公司通过在欧洲市场推出Varipulse Pro产品，进一步拓展了其脉冲电场消融技术产品线。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770993.USD","IE00BFXG1179.USD","IE00BBT3K403.USD","IE00B42XCP33.USD","LU1023059063.AUD","LU0985320562.USD","LU1121112475.USD","LU2602419157.SGD","LU1894683348.USD","IE00B1BXHZ80.USD","LU1244550577.SGD","LU2592432038.USD","LU1066051498.USD","LU1430594728.SGD","IE0034235303.USD","LU0795875169.SGD","LU1267930813.SGD","LU1778281490.HKD","IE00BKVL7J92.USD","LU1280957306.USD","LU1066053197.SGD","LU2471134523.USD","BK4007","LU0466842654.USD","LU2430703178.SGD","LU2750360997.AUD","LU1674673691.USD","LU2471134796.USD","LU0345770308.USD","SG9999002232.USD","LU2347655156.SGD","IE00BZ1G4Q59.USD","LU1221951046.USD","LU1043141396.HKD","LU2430703095.HKD","IE000M9KFDE8.USD","LU0124676726.USD","LU1196500208.SGD","IE00B2B36J28.USD","LU0787776722.HKD","IE0000B7K699.USD","IE00BGHQF631.EUR","BK4533","LU0122379950.USD","LU1074936037.SGD","BK4534","LU2129689514.USD","LU2129689605.HKD","LU0345769631.USD","SG9999002224.SGD","LU0234572021.USD","IE00BVYPNW00.USD","IE00BLSP4239.USD","LU0792757196.USD","IE000MB6IJN5.SGD","IE00BLSP4452.SGD","LU2750360641.GBP","LU2505996681.GBP","LU1935042991.SGD","IE000BZT7R73.USD","LU1585245621.USD","IE0002141913.USD","LU1032955483.USD","IE00BN8TJ469.HKD","LU0320765646.SGD","LU1894683264.USD","LU0058720904.USD","IE000F7OJYX1.SGD","LU0432979614.USD","IE00B7SZLL34.SGD","JNJ","BK4581","LU0114720955.EUR","LU0912757837.SGD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","IE0009355771.USD","LU0098860793.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","IE00B3PB1722.GBP","LU1059921491.USD","LU1914381329.SGD","LU0289739699.SGD","BK4504","LU0070217475.USD","LU1032466523.USD","BK4532","IE00B19Z3581.USD","LU1061106388.HKD","LU0426412945.USD","LU1496350502.SGD","LU2430703251.USD","LU2133065610.SGD","LU1732800096.USD","LU1929549753.HKD","LU2471134952.CNY","BK4568","IE000WAW04H5.SGD","LU2468319806.SGD","LU1066051225.USD","LU1506573853.SGD","LU1057294990.SGD","LU0882574055.USD","LU2471134879.HKD","LU2129689431.USD","LU0689626769.HKD","IE00BVYPNV92.GBP","LU0234570918.USD","IE00BDGV0183.EUR","LU1261432733.SGD","BK4592","IE000SO60NU8.SGD","SG9999001440.SGD","BK4585","LU0426417589.USD","IE00BJJMRZ35.SGD","LU0345769128.USD","LU1221951129.SGD","LU1718418525.SGD","LU1066051811.HKD","LU2505996509.AUD","BK4559","LU0203347892.USD","LU1732799900.SGD","IE00B19Z3B42.SGD","LU1983299246.USD","IE00B4R5TH58.HKD","LU1162221912.USD","LU0994945656.USD","BK4550","LU1244550494.USD","LU1043141123.HKD","LU2089984988.USD","BK4588","LU1674673428.USD","IE00B3T34201.USD","LU1244550221.USD","IE0002270589.USD","IE0001KFT4U8.USD","LU0795875086.SGD","LU0889566641.SGD","LU0203345920.USD","LU0640476718.USD","LU0683600562.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":62,"code":"91000000","status":"200"}]}}